Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term Surface nuclear-penetrating molecular drill enzyme does not refer to a naturally occurring biological enzyme or a standard therapeutic receptor. Instead, it describes a class of synthetic, light-activated molecular machines, often referred to as molecular motors or drills, developed for nanomedicine applications. These molecules, typically based on unidirectional rotary motors like those pioneered by Bernard Feringa, are designed to rotate at millions of cycles per second when triggered by specific wavelengths of light. This mechanical action allows them to physically drill through cellular and nuclear membranes, either to induce direct cell death (necrosis) or to facilitate the delivery of therapeutic payloads. While they are highly effective in vitro against cancer cells and antibiotic-resistant bacteria, they are considered experimental tools or delivery systems rather than traditional drug targets.
Mechanical disruption of lipid bilayers via high-frequency rotation (2-3 MHz) upon activation by ultraviolet or visible light, leading to cell death or increased membrane permeability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Surface nuclear-penetrating molecular drill enzyme (SNP-drill).